Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1996 | 03-1996 | 12-1995 | 09-1995 | 06-1995 | |
| Sales | 61,619 | 45,542 | 43,297 | 38,521 | 36,993 |
| Cost of Goods | 37,649 | 18,716 | 23,049 | 16,831 | 12,623 |
| Gross Profit | 55,499 | 26,826 | 38,224 | 21,690 | 14,312 |
| Operating Expenses | 17,998 | 9,434 | 18,176 | 9,080 | 5,295 |
| Operating Income | 6,621 | 18,108 | 2,121 | 13,441 | 19,698 |
| Interest Expense | 0 | 0 | -119 | 0 | 0 |
| Other Income | 44,450 | 6,507 | 37,959 | -653 | -9,495 |
| Pre-tax Income | 51,071 | 24,615 | 40,199 | 12,788 | 10,203 |
| Income Tax | 16,120 | 7,630 | 9,874 | 7,481 | 3,835 |
| Net Income Continuous | 18,819 | 16,985 | 16,880 | 5,307 | 13,314 |
| Net Income | $18,819 | $16,985 | $16,880 | $5,307 | $13,314 |
| EPS Basic Total Ops | 0.24 | 0.23 | 0.23 | 0.07 | 0.18 |
| EPS Basic Continuous Ops | 0.25 | 0.23 | 0.22 | 0.07 | 0.18 |
| EPS Diluted Total Ops | 0.22 | 0.23 | 0.23 | 0.07 | 0.18 |
| EPS Diluted Continuous Ops | 0.22 | 0.23 | 0.22 | 0.07 | 0.18 |
| EBITDA(a) | $8,179 | $19,559 | $2,121 | $13,441 | $19,698 |